Close



May 21, 2024 08:02AM
May 16, 2024 08:01AM
May 7, 2024 08:01AM
May 2, 2024 04:02PM
May 1, 2024 08:00AM
Feb 22, 2024 04:01PM
Jan 8, 2024 08:05AM Ardelyx (ARDX) Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
Jan 8, 2024 08:00AM
Jan 3, 2024 08:03AM
Nov 15, 2023 04:02PM
Nov 15, 2023 04:02PM
Nov 13, 2023 04:03PM
Nov 13, 2023 04:02PM
Nov 6, 2023 08:02AM Ardelyx (ARDX) Announces XPHOZAH now Available in the US
Nov 6, 2023 08:00AM
Nov 3, 2023 08:00AM
Nov 3, 2023 08:00AM
Oct 31, 2023 07:00AM
Oct 23, 2023 08:07AM
Oct 23, 2023 08:07AM
Oct 18, 2023 05:05AM Ardelyx (ARDX) 30-day option implied volatility into action date
Oct 17, 2023 07:30PM
Oct 17, 2023 07:30PM
Oct 17, 2023 07:23PM
Oct 17, 2023 07:01PM
Oct 17, 2023 05:15AM
Oct 16, 2023 10:58AM
Oct 16, 2023 04:53AM Ardelyx (ARDX) call put ratio 4.1 calls to 1 put into FDA action date
Oct 13, 2023 11:28AM
Oct 13, 2023 07:18AM
Sep 28, 2023 08:02AM
Sep 28, 2023 08:02AM
Sep 25, 2023 06:56AM
Sep 25, 2023 04:15AM
Sep 7, 2023 06:06AM H.C. Wainwright Starts Ardelyx, Inc (ARDX) at Buy 'Ahead of the potential approval of XPHOZAH next quarter'
Aug 2, 2023 07:00AM
May 17, 2023 07:30AM
May 17, 2023 07:30AM
May 9, 2023 08:03AM
May 9, 2023 08:00AM
May 3, 2023 04:02PM
Apr 18, 2023 08:03AM Ardelyx (ARDX) Resubmits New Drug Application to U.S. Food and Drug Administration for XPHOZAH (tenapanor)
Apr 18, 2023 08:00AM
Apr 18, 2023 08:00AM
Mar 2, 2023 04:02PM
Mar 2, 2023 04:02PM
Dec 29, 2022 03:21PM
Dec 29, 2022 07:00AM
Dec 29, 2022 07:00AM FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor)
Dec 19, 2022 05:11AM

258,211 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All